Skull Base Tumors

  • Anitha Raghunath
  • Jade S. Schiffman
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)


Ocular manifestations are not infrequent in the presence of skull base tumors because of the crucial visual and oculomotor pathways traversing the skull base. Because familiarity with the intricate skull base anatomy is imperative for accurately diagnosing and effectively managing skull base tumors, this chapter provides a description of the anatomy of the skull base and a discussion of imaging techniques. Numerous types of tumors and their neuro-ophthalmologic correlations are also discussed, including esthesioneuroblastomas, chordomas, craniopharyngiomas, meningiomas, sinonasal tumors, schwannomas, pituitary tumors, myelomas, paragangliomas, and metastases.


Skull Base Cavernous Sinus Visual Field Defect Optic Canal Pituitary Apoplexy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Davis FG, McCarthy BJ, Berger MS. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Database. Neuro Oncol 1999;1(3):205–11.PubMedGoogle Scholar
  2. 2.
    Durden DD, Williams DWI. Radiology of skull base neoplasms. Otolaryngol Clin North Am 2001;34(6):1043–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Atlas SW. Magnetic Resonance Imaging of the Brain and Spine, Vol 2, third edition. Baltimore, MD: Lippincott Williams & Wilkins, 2002.Google Scholar
  4. 4.
    Som PM, Curtin HD. Head and Neck Imaging, fourth edition. St Louis, MO: Mosby, 2003.Google Scholar
  5. 5.
    Lufkin R, Borges A, Villablanca P. Teaching Atlas of Head and Neck Imaging, first edition. New York, NY: Thieme, 2000.Google Scholar
  6. 6.
    Chong VF, Fan YF, Tng CH. Pictorial review: radiology of the sphenoid bone. Clin Radiol 1998;53(12):882–93.PubMedCrossRefGoogle Scholar
  7. 7.
    Fischbein NJ, Kaplan MJ. Magnetic resonance imaging of the central skull base. Top Magn Reson Imaging 1999;10(5):325–46.PubMedCrossRefGoogle Scholar
  8. 8.
    Tomura, Hirano H, Sashi R, et al. Comparison of MR imaging and CT in discriminating tumor infiltration of bone and bone marrow in the skull base. Comput Med Imaging Graph 1998;22(1):41–51.PubMedCrossRefGoogle Scholar
  9. 9.
    Williams L. Advanced concepts in the imaging of perineural spread of tumor to the trigeminal nerve. Topics Magn Reson Imaging 1999;10(6):376–83.CrossRefGoogle Scholar
  10. 10.
    Borges A, Casselman J. Skull base tumours part I: imaging technique, anatomy, and anterior skull base tumours. Eur J Radiol 2008;66(3):338–47.PubMedCrossRefGoogle Scholar
  11. 11.
    Borges AR, Lufkin RB, Huang AY, Farahani K, Arnold AC. Frequency-selective fat suppression MR imaging. Localized asymmetric failure of fat suppression mimicking orbital disease. J Neuroophthalmol 1997;17(1):12–7.PubMedCrossRefGoogle Scholar
  12. 12.
    DeAngelis L. Current diagnosis and treatment of leptomeningeal metastasis. J Neurooncol 1998;38:245–52.PubMedCrossRefGoogle Scholar
  13. 13.
    de Champs C, Demeocq F, Merie P, et al. Olfactory neuroblastoma disclosed by blindness in a 9-month-old girl [in French]. Arch Fr Pediatr 1985;42(2):119–21.PubMedGoogle Scholar
  14. 14.
    Ramsay HA, Kairemo KJ, Jekunen AP. Somatostatin receptor imaging of olfactory neuroblastoma. J Laryngol Otol 1996;110(12):1161–3.PubMedCrossRefGoogle Scholar
  15. 15.
    DeAngelis LM, Gutin PH, Leibel SA, Posner JB. Intracranial Tumors: Diagnosis and Treatment, first edition. London, UK: Martin Dunitz, 2002.Google Scholar
  16. 16.
    Guy J, Mancuso A, Beck R, Moster ML, Sedwick LA, Quisling RG, Rhoton AL, Jr., Protzko EE, Schiffman J. Radiation-induced optic neuropathy: a magnetic resonance imaging study. J Neurosurg 1991;74(3):426–32.PubMedCrossRefGoogle Scholar
  17. 17.
    Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O’Fallon JR, Dozier JC, Piepgras DG. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg 1993;78(5):741–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Miller SJ. Ocular signs of chordomas. Proc R Soc Med 1972;65(6):522–3.PubMedGoogle Scholar
  19. 19.
    Agrawal PP, Bahadur AK, Mohanta PK, et al. Chordoma: 6 years’ experience at a tertiary centre. Australas Radiol 2006;50(3):201–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Konuk O, Pehlivanli Z, Yirmibesoglu E, Erkal HS, Erekul S, Unal M. Compressive optic neuropathy due to orbital metastasis of a sacral chordoma: case report. Ophthal Plast Reconstr Surg 2005;21(3):245–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Lanzino G, Dumont AS, Lopes MB, Laws ER, Jr. Skull base chordomas: overview of disease, management options, and outcome. Neurosurg Focus 2001;10(3):E12.PubMedCrossRefGoogle Scholar
  22. 22.
    Ikushima I, Korogi Y, Hirai T, Hamatake S, Takahashi M, Ushio Y. Chordomas of the skull base: dynamic MRI. J Comput Assist Tomogr 1996;20(4):547–50.PubMedCrossRefGoogle Scholar
  23. 23.
    Dehdashti AR, Karabatsou K, Ganna A, Witterick I, Gentili F. Expanded endoscopic endonasal approach for treatment of clival chordomas: early results in 12 patients. Neurosurgery 2008;63(2):299–307; discussion 307–309.PubMedCrossRefGoogle Scholar
  24. 24.
    Hong Jiang W, Ping Zhao S, Hai Xie Z, Zhang H, Zhang J, Yun Xiao J. Endoscopic resection of chordomas in different clival regions. Acta Otolaryngol 2009;129(1):71–83.PubMedCrossRefGoogle Scholar
  25. 25.
    Chen C, Okera S, Davies PE, Selva D, Crompton JL. Craniopharyngioma: a review of long-term visual outcome. Clin Exp Ophthalmol 2003;31(3):220–8.CrossRefGoogle Scholar
  26. 26.
    Repka MX, Miller NR, Miller M. Visual outcome after surgical removal of craniopharyngiomas. Ophthalmology 1989;96(2):195–9.PubMedGoogle Scholar
  27. 27.
    Kennedy HB, Smith RJ. Eye signs in craniopharyngioma. Br J Ophthalmol 1975;59(12):689–95.PubMedCrossRefGoogle Scholar
  28. 28.
    Paul TO, Hoyt WF. Funduscopic appearance of papilledema with optic tract atrophy. Arch Ophthalmol 1976;94(3):467–8.PubMedCrossRefGoogle Scholar
  29. 29.
    Rockhill J, Mrugala M, Chamberlain MC. Intracranial meningiomas: an overview of diagnosis and treatment. Neurosurg Focus 2007;23(4):E1.PubMedCrossRefGoogle Scholar
  30. 30.
    De Monte F. Current management of meningiomas. Oncology (Williston Park) 1995;9(1):83–91, 96.Google Scholar
  31. 31.
    Antinheimo J, Sankila R, Carpen O, Pukkala E, Sainio M, Jaaskelainen J. Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 2000;54(1):71–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, Viskochil D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997;278(1):51–7.PubMedCrossRefGoogle Scholar
  33. 33.
    King A, Gutmann DH. The question of familial meningiomas and schwannomas: NF2B or not to be? Neurology 2000;54(1):4–5.PubMedCrossRefGoogle Scholar
  34. 34.
    Wilson CB. Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg 1994;81(5):666–75.PubMedCrossRefGoogle Scholar
  35. 35.
    Elder JB, Atkinson R, Zee CS, et al. Primary intraosseous meningioma. Neurosurg Focus 2007;23(4):E13.PubMedCrossRefGoogle Scholar
  36. 36.
    Barnholtz-Sloan JS, Kruchko C. Meningiomas: causes and risk factors. Neurosurg Focus 2007;23(4):E2.PubMedCrossRefGoogle Scholar
  37. 37.
    Olivero WC, Lister JR, Elwood PW. The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 1995;83(2):222–4.PubMedCrossRefGoogle Scholar
  38. 38.
    Berman DM, Miller NR. New concepts in the management of optic nerve sheath meningiomas. Ann Acad Med Singapore 2006;35(3):168–74.PubMedGoogle Scholar
  39. 39.
    Hollenhorst RW Jr, Hollenhorst RW Sr, MacCarty CS. Visual prognosis of optic nerve sheath meningiomas producing shunt vessels on the optic disk: the Hoyt-Spencer syndrome. Trans Am Ophthalmol Soc 1977;75:141–63.PubMedGoogle Scholar
  40. 40.
    Saeed P, Rootman J, Nugent RA, et al. Optic nerve sheath meningiomas. Ophthalmology 2003;110(10):2019–30.PubMedCrossRefGoogle Scholar
  41. 41.
    Moster ML. Detection and treatment of optic nerve sheath meningioma. Curr Neurol Neurosci Rep 2005;5(5):367–75.PubMedCrossRefGoogle Scholar
  42. 42.
    Hao SP, Ngan MT, Kupferman ME. Nasopharyngeal carcinoma. In: Practical Head and Neck Oncology. Petruzzelli GJ, editor. San Diego, CA: Plural Publishing, 2009:640.Google Scholar
  43. 43.
    DeMonte F, Gilbert MR, Mahajan A, McCutcheon IE. Tumors of the Brain and Spine, first edition. New York, NY: Springer, 2007.CrossRefGoogle Scholar
  44. 44.
    Sabel LH, Teepen JL. The enigmatic origin of olfactory schwannoma. Clin Neurol Neurosurg 1995;97(2):187–91.PubMedCrossRefGoogle Scholar
  45. 45.
    Zhang L, Yang Y, Xu S, Wang J, Liu Y, Zhu S. Trigeminal schwannomas: a report of 42 cases and review of the relevant surgical approaches. Clin Neurol Neurosurg 2009;111(3):261–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Honda K, Asato R, Tanaka S, Endo T, Nishimura K, Ito J. Vidian nerve schwannoma with middle cranial fossa extension resected via a maxillary swing approach. Head Neck 2008;30(10):1389–93.PubMedCrossRefGoogle Scholar
  47. 47.
    Zhao H, Li X, Lv Q, Yuan Y, Yu H. A large dumbbell glossopharyngeal schwannoma involving the vagus nerve: a case report and review of the literature. J Med Case Reports 2008;2:334.CrossRefGoogle Scholar
  48. 48.
    Ohba S, Miwa T, Kawase T. Trochlear nerve schwannoma with intratumoral hemorrhage: case report. Neurosurgery 2006;58(4):E791; discussion E791.PubMedCrossRefGoogle Scholar
  49. 49.
    Boggan JE, Rosenblum ML, Wilson CB. Neurilemmoma of the fourth cranial nerve. Case report. J Neurosurg 1979;50(4):519–21.PubMedCrossRefGoogle Scholar
  50. 50.
    Nadkarni TD, Goel A. Trochlear nerve neurinoma presenting as pathological laughter. Br J Neurosurg 1999;13(2):212–3.PubMedCrossRefGoogle Scholar
  51. 51.
    Shenouda EF, Ghosh A, Coakham HB. Trochlear nerve schwannoma removed by combined petrosal approach. Br J Neurosurg 2002;16(6):600–4.PubMedGoogle Scholar
  52. 52.
    Bulsara KR, Sameshima T, Friedman AH, Fukushima T. Microsurgical management of 53 jugular foramen schwannomas: lessons learned incorporated into a modified grading system. J Neurosurg 2008;109(5):794–803.PubMedCrossRefGoogle Scholar
  53. 53.
    Wang H, Sun W, Fu Z, Si Z, Zhu Y, Zhai G, Zhao G, Xu S, Pang Q. The pattern of visual impairment in patients with pituitary adenoma. J Int Med Res 2008;36(5):1064–9.PubMedGoogle Scholar
  54. 54.
    Nawar RN, AbdelMannan D, Selman WR, Arafah BM. Pituitary tumor apoplexy: a review. J Intensive Care Med 2008;23(2):75–90.PubMedCrossRefGoogle Scholar
  55. 55.
    Randeva HS, Schoebel J, Byrne J, Esiri M, Adams CB, Wass JA. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 1999;51(2):181–8.CrossRefGoogle Scholar
  56. 56.
    Knoepfelmacher M, Gomes MC, Melo ME, Mendonca BB. Pituitary apoplexy during therapy with cabergoline in an adolescent male with prolactin-secreting macroadenoma. Pituitary 2004;7(2):83–7.PubMedCrossRefGoogle Scholar
  57. 57.
    Nagarajan DV, Bird D, Papouchado M. Pituitary apoplexy following anticoagulation for acute coronary syndrome. Heart 2003;89(1):10.PubMedCrossRefGoogle Scholar
  58. 58.
    Semple PL, Webb MK, de Villiers JC, Laws ER, Jr. Pituitary apoplexy. Neurosurgery 2005;56(1):65–72; discussion 72–73.PubMedGoogle Scholar
  59. 59.
    Higurashi M, Yagishita S, Fujitsu K, Kitsuta Y, Takemoto Y, Osano S. Plasma cell myeloma of the skull base: report of two cases. Brain Tumor Pathol 2004;21(3):135–41.PubMedCrossRefGoogle Scholar
  60. 60.
    Silverstein A, Doniger DE. Neurologic complications of myelomatosis. Arch Neurol 1963;9:534–44.PubMedCrossRefGoogle Scholar
  61. 61.
    Kanemura N, Tsurumi H, Hara T, Yamada T, Sawada M, Moriwaki H. [Multiple myeloma complicated by bilateral abducens nerve palsy due to a tumor in the clivus]. Rinsho Ketsueki 2001;42(3):218–20.PubMedGoogle Scholar
  62. 62.
    Movsas TZ, Balcer LJ, Eggenberger ER, Hess JL, Galetta SL. Sixth nerve palsy as a presenting sign of intracranial plasmacytoma and multiple myeloma. J Neuroophthalmol 2000;20(4):242–5.PubMedCrossRefGoogle Scholar
  63. 63.
    Miyazaki T, Taguchi J, Obana T, Yamaji S, Koharazawa H, Fujimaki K, Kanamori H, Ishigatsubo Y. [Multiple myeloma presenting as cavernous sinus syndrome]. Rinsho Ketsueki 2006;47(10):1393–5.PubMedGoogle Scholar
  64. 64.
    Willinsky RA, Cooper PW, Kassel EE. CT of myeloma involving the skull base. J Can Assoc Radiol 1985;36(4):328–31.PubMedGoogle Scholar
  65. 65.
    Moyer JS, Bradford CR. Sympathetic paraganglioma as an unusual cause of Horner’s syndrome. Head Neck 2001;23(4):338–42.PubMedCrossRefGoogle Scholar
  66. 66.
    Angeli SI, Sato Y, Gantz BJ. Glomus jugulare tumors masquerading as benign intracranial hypertension. Arch Otolaryngol Head Neck Surg 1994;120(11):1277–80.PubMedCrossRefGoogle Scholar
  67. 67.
    Hierons R, Meadows SP. Glomus jugulare tumour presenting with papilloedema and obscurations of vision. Proc R Soc Med 1954;47(4):298–9.PubMedGoogle Scholar
  68. 68.
    Venkatesh P, Verma L, Tewari H. Decreased vision as presenting feature in childhood paraganglioma. Indian Pediatr 2002;39(7):681–4.PubMedGoogle Scholar
  69. 69.
    Voulgaris SG, Partheni M, Tzortzidis F, Ravazoula P, Pessach IS, Papadakis N, Polyzoidis KS. Suprasellar and intrasellar paragangliomas. Clin Neuropathol 2006;25(5):221–6.PubMedGoogle Scholar
  70. 70.
    Peltier J, Fichten A, Lefranc M, Grunewald P, Thelu F, Toussaint P, Desenclos C, Le Gars D. [Paraganglioma of the cavernous sinus. Case report]. Neurochirurgie 2007;53(5):391–4.PubMedCrossRefGoogle Scholar
  71. 71.
    Sharma MC, Epari S, Gaikwad S, Verma A, Sarkar C. Orbital paraganglioma: report of a rare case. Can J Ophthalmol 2005;40(5):640–44.PubMedGoogle Scholar
  72. 72.
    Venkataramana NK, Kolluri VR, Kumar DV, Rao TV, Das BS. Paraganglioma of the orbit with extension to the middle cranial fossa: case report. Neurosurgery 1989;24(5):762–4.PubMedCrossRefGoogle Scholar
  73. 73.
    Laigle-Donadey F, Taillibert S, Martin-Duverneuil N, Hildebrand J, Delattre JY. Skull-base metastases. J Neurooncol 2005;75(1):63–9.PubMedCrossRefGoogle Scholar
  74. 74.
    Greenberg HS, Deck MD, Vikram B, Chu FC, Posner JB. Metastasis to the base of the skull: clinical findings in 43 patients. Neurology 1981;31(5):530–7.PubMedCrossRefGoogle Scholar
  75. 75.
    Mubaidin SI, Sunna JB, Beiruti MA, Shennak MM, Ayoub MS. Renal cell carcinoma presenting as Garcin’s syndrome. J Neurol Neurosurg Psychiatry 1990;53(7):613–4.PubMedCrossRefGoogle Scholar
  76. 76.
    Julien J, Ferrer X, Drouillard J, Philippe JC, Desbordes P. Cavernous sinus syndrome due to lymphoma. J Neurol Neurosurg Psychiatry 1984;47(5):558–60.PubMedCrossRefGoogle Scholar
  77. 77.
    Aung TH, Po YC, Wong WK. Hepatocellular carcinoma with metastasis to the skull base, pituitary gland, sphenoid sinus, and cavernous sinus. Hong Kong Med J 2002;8(1):48–51.PubMedGoogle Scholar
  78. 78.
    Johnston JL. Parasellar syndromes. Curr Neurol Neurosci Rep 2002;2(5):423–31.PubMedCrossRefGoogle Scholar
  79. 79.
    Reiter R, Allert M, Knuchel R, Strutz J. [Sinugenic metastasis of bilateral renal cell carcinoma (hypernephroma)]. HNO 2002;50(2):165–8.PubMedCrossRefGoogle Scholar
  80. 80.
    Post MJ, Mendez DR, Kline LB, Acker JD, Glaser JS. Metastatic disease to the cavernous sinus: clinical syndrome and CT diagnosis. J Comput Assist Tomogr 1985;9(1):115–20.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Section of Ophthalmology, Department of Head and Neck SurgeryThe University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations